Clinical Trial Update: Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide, dexamethasone, and clarithromycin in patients who have undergone stem cell transplant for multiple myeloma; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-03-21